Point72 Asset Management, L.P.

Position in GMAB — Genmab A/S

CIK 1603466 STAMFORD, CT

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,726,223

-$7,399,187 QoQ

Shares Held

135,647

-74.8% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#52

of 292 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. GMAB ranks #85 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	4,473,478	$158,316,386
2	CYTK	Cytokinetics Inc	1,587,712	$135,257,185
3	BBIO	BridgeBio Pharma, Inc.	1,525,782	$113,640,243
4	AXSM	Axsome Therapeutics, Inc.	416,516	$101,950,621
5	LEGN	Legend Biotech Corp	3,076,124	$88,838,461
6	MDGL	Madrigal Pharmaceuticals, Inc.	137,029	$73,577,721
7	CELC	Celcuity Inc.	650,916	$68,098,831
8	ACAD	Acadia Pharmaceuticals Inc	2,433,168	$61,559,150

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,726,223	135,647	-74.8%	Shares	Defined	2026-08-14
2025-06-30	$11,125,410	538,500	-41.7%	Shares	Defined	2025-08-14
2025-03-31	$18,089,315	923,867	+948.1%	Shares	Defined	2025-07-21
2024-12-31	$1,839,607	88,146	+384.7%	Shares	Defined	2025-02-14
2024-06-30	$456,963	18,184	-82.0%	Shares	Defined	2024-09-16
2023-12-31	$3,219,024	101,100	-63.7%	Shares	Defined	2024-02-14
2023-09-30	$9,826,257	278,601	+57.0%	Shares	Defined	2023-11-14
2023-06-30	$6,746,775	177,500	-31.9%	Shares	Defined	2023-08-14
2023-03-31	$9,846,524	260,766	+360.7%	Shares	Defined	2023-05-15
2021-09-30	$2,473,420	56,600	-87.2%	Shares	Defined	2021-11-15
2021-06-30	$18,030,528	441,600	+93.1%	Shares	Defined	2021-08-16
2021-03-31	$7,508,221	228,700	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.